MedPath

A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition

Phase 2
Completed
Conditions
Severe Acute Malnutrition
Interventions
Dietary Supplement: Standard RUTF
Dietary Supplement: RUTF/Flax Oil
Dietary Supplement: RUTF/Flax Oil plus additional Fish Oil
Registration Number
NCT01593969
Lead Sponsor
University of Oxford
Brief Summary

The investigators will perform a randomised controlled trial of the provision of food designed for rehabilitation of malnourished children that is supplemented with n-3 fatty acids compared to usual composition. The investigators want to see whether the provision of such a food normalises the deficiencies in essential fatty acids observed in severely malnourished children faster than standard composition.

Detailed Description

Randomized controlled trial of n-3 Polyunsaturated Fatty Acid-Enriched Therapeutic Food for Severe Malnutrition.

Description of Study Design: Randomized Controlled Trial

Study Duration: 6 months (Trial); 12 months (All trial-related activities)

Description of Intervention: Provision of ready to use food (RUTF) enriched with flax seed oil, with or without fish oil, compared to conventional-composition RUTF. Interventional product will be given until nutritional recovery to a maximum of 12 weeks.

Design: Flax-enriched or standard RUTF allocation is randomised and double blind. Fish oil allocation is randomised within those receiving flax-enriched RUTF and is open label.

Location: Kilifi District, coastal Kenya.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Children aged 6 months to 5 years old
  • Provision of informed consent
  • Severe malnutrition (one or more of mid-upper arm circumference <11.5cm, weight for height z score <-3, or nutritional oedema)
  • Stabilised and eligible to receive RUTF according to national guidelines
Exclusion Criteria
  • Known HIV disease, tuberculosis or other chronic infection*

  • Known allergy or hypersensitivity to any of the product ingredients

    • Chronic infections such as HIV and tuberculosis and their treatments are likely to cause alterations in lipid metabolism that may confound interpretation of this pilot trial. national guidelines recommend offering provider-initiated testing for HIV for all severely malnourished children, and referral for comprehensive care in the case of a positive test.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard RUTFStandard RUTFStandard RUTF given according to National Guidelines
RUTF/Flax OilRUTF/Flax OilRUTF/Flax Oil is reformulated RUTF to increase n3 content
RUTF/Flax Oil plus additional Fish OilRUTF/Flax Oil plus additional Fish OilRUTF/Flax Oil plus additional Fish Oil is RUTF reformulated to increase n3. Fish oil to provide long chain n3
Primary Outcome Measures
NameTimeMethod
Total long chain PUFA in erythrocyte membranes at 3 months3 months

Total long chain PUFA in erythrocyte membranes at 3 months

Secondary Outcome Measures
NameTimeMethod
Change in weight for height z score between baseline and 3 months3 months

Change in weight for height z score between baseline and 3 months

Ratio of n-6:n-3 PUFA in erythrocyte membranes at 3 months3 months

Ratio of n-6:n-3 PUFA in erythrocyte membranes at 3 months

Total long chain PUFA in plasma at 3 months3 months

Total long chain PUFA in plasma at 3 months

Change in mid upper arm circumference between baseline and 3 months3 months

Change in mid upper arm circumference between baseline and 3 months

Ratio of n-6:n-3 PUFA in CD3 cell membranes at 3 months3 months

Ratio of n-6:n-3 PUFA in CD3 cell membranes at 3 months

Total long chain PUFA in CD3 cell membranes at 3 months3 months

Total long chain PUFA in CD3 cell membranes at 3 months

Ratio of n-6:n-3 PUFA in plasma at 3 months3 months

Ratio of n-6:n-3 PUFA in plasma at 3 months

Trial Locations

Locations (1)

Kilifi District Hospital

🇰🇪

Kilifi, Coast, Kenya

© Copyright 2025. All Rights Reserved by MedPath